pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hypertriglyceridemia · news · pharmadog
← back to Hypertriglyceridemia
News mentioning Hypertriglyceridemia
14
stories
11d
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
biospace
17d
Lisata deal propels Marea’s drug pipeline to Wall Street
biopharma dive
17d
After one failed acquisition attempt, Lisata finds lifeline in Marea merger
fiercebiotech
20d
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
fiercebiotech
Sep 3, 26
FDA approves Ionis’ antisense drug as first targeted therapy for Alexander disease
biospace
Aug 31, 26
ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy
biopharma dive
Aug 31, 26
Arrowhead's new Redemplo findings in severe hypertriglyceridemia have analysts split
biospace
Aug 20, 26
Scribe’s early-stage IPO standout defies biotech’s derisking trend
biospace
Aug 19, 26
FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
fda press
Aug 7, 26
‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit
biopharma dive
Jul 29, 26
Biotechs bring big launches and pharma rivalries into Q2 earnings period
biospace
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jul 22, 26
Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug
biospace
